Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-Fraumeni Syndrome) and the use of magnetic resonance imaging (MRI) and ultrasound to improve treatments for breast cancer.
Two teams primarily based in Ontario and the other in BC will receive the funding from the Terry Fox Research Institute (TFRI) as winners of its 2018 Terry Fox New Frontiers Program Project Grant (PPGs) competition.
“These three teams have demonstrated that they are able to think outside the box and create really innovative projects that tackle some of the most challenging problems in cancer research. They bring together leading researchers with complementary skills to investigate different aspects of a given area of cancer research to find solutions that could yield positive results for patients in the short term,” says Dr. Victor Ling, TFRI president and scientific director.
The projects were selected after a rigorous process that saw a committee of international experts visit six short-listed labs before making a final decision on the award recipients.
